ScholarMate
English简体中文繁體中文
Customer service: 400-1616-289
Sign inSign up
Journal article

Patients Undergoing Primary Total Joint Arthroplasty with Primary Hypercoagulable States

Pan, Xin; Shi, Zhe; Shi, Zhan-jun; Yang, Zhang; Lin, Ze-ming; Wu, Xuan-ping; Wang, Jian*南方医科大学; 1
Orthopaedic Surgery2021-4DOI: 10.1111/os.12901
9Reads
CiteSave
Share

Abstract

Objective To analyze perioperative complications, resource consumption, and inpatient mortality of patients who receive total joint arthroplasty (TJA) with a concomitant diagnosis of a primary hypercoagulable state (PHS). The following questions were posed in the present paper. First, do patients undergoing TJA with PHS have increased risk of deep venous thrombosis (DVT), pulmonary embolism (PE), and periprosthetic joint infection (PJI)? Second, what other in-hospital complications are more likely among PHS patients undergoing TJA? Third, do TJA patients with PHS usually consume greater in-hospital resources? Fourth, do PHS patients suffer higher mortality rates compared to non-PHS patients? Finally, have PHS patients received proper anticoagulant management in past arthroplasties? @@@ Methods The National Inpatient Sample (NIS) database for the years between 2003 and 2014 was searched to identify patients undergoing primary TJA. Patients with PHS were identified with the ICD-9-CM code 289.81. The chi(2)-test, the Pearson test, and adjusted multivariate regression analysis were performed to evaluate the difference and odds ratios between the positive and negative diagnosis groups. @@@ Results From 2003 to 2014, a total of 2,044,356 patients were identified in the NIS as undergoing primary total hip arthroplasty (THA) or total knee arthroplasty (TKA) in the United States. A total of 4664 patients (0.2%) were identified as having PHS. Compared with the non-PHS group, TJA patients with PHS had a higher risk of DVT (THA: odds ratio [OR] = 8.343, 95% CI: 5.362-12.982, P < 0.001; TKA: OR = 4.712, 95% CI: 3.560-6.238, P < 0.001) but did not have increased risk of PE (THA: OR = 1.306, 95% CI: 0.48-3.555, P = 0.602; TKA: OR = 1.143, 95% CI: 0.687-1.903), and only PHS patients in the THA group had higher risks of inpatient mortality (OR = 3.184, 95% CI: 1.348-7.522, P = 0.008) and periprosthetic joint infection (OR = 3.343, 95% CI: 1.084-10.879, P = 0.036). In addition, PHS patients had extended length of stay, higher total costs, and increased risks of certain other complications, such as peripheral vascular disease, hemorrhage, and thrombophlebitis. @@@ Conclusion In the present study, PHS patients had higher risks of DVT, greater in-hospital resource consumption, and certain other perioperative complications. However, PHS was not associated with increased risk of PE in TJA patients in the United States between 2003 and 2014. While potential hazards of PHS have already been recognized, the present study revealed additional concerns and demonstrated that further improvements in the perioperative management of patients with hereditary hypercoagulable disorders are essential.

Disciplines and keywords

Keywords
Perioperative complicationPrimaryhypercoagulable stateResource consumptionTotal joint arthroplasty
Related
Loading…

Could not load papers. Please retry.

Retry

Publication info

Publication status
Published
Journal
Orthopaedic Surgery
Publication date
2021-04
Volume / issue
Vol. 13, Issue 2
Pages
442-450
DOI
10.1111/os.12901
Language
ENGLISH
Journal indexing
NSL
Journal ranking
Q2
Output indexing
SCIE
Funding acknowledgment
Southern Medical University 2016 "Clinical Research Startup Plan" Seedling Project [LC2016YM003]

Authors

  • P

    Pan, Xin (First author)

    southern med univ · 1

  • S

    Shi, Zhe

    southern med univ

View all 7 authorsShow fewer authors
  • S

    Shi, Zhan-jun

    southern med univ

  • Y

    Yang, Zhang

    southern med univ

  • L

    Lin, Ze-ming

    southern med univ

  • W

    Wu, Xuan-ping

    southern med univ

  • W

    Wang, Jian (Corresponding)

    southern med univ

Sign in for more features

  • Save this paper in My collections
  • Claim your outputs and generate promotion materials
  • Follow authors for new outputs
  • Join groups and collaborate
Sign up / Sign in

Products

  • ScholarMate
  • InnoCity
  • IRISaaS

Support

  • Help Center
  • Privacy Policy
  • Terms of Service

Contact

Online support: []
Customer service: 400-1616-289
Email: support@scholarmate.com

Follow or download ScholarMate

WeChat QR code
WeChat official account
App download QR code
Download the app
OutputsResearchersResearch institutionsResearch newsIRISaaS

©2026 深圳市科研之友网络服务有限公司

Public security registration badge粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417